<DOC>
	<DOCNO>NCT00084071</DOCNO>
	<brief_summary>The purpose study determine whether tifacogin effective safe treatment patient severe community-acquired pneumonia .</brief_summary>
	<brief_title>Tifacogin Treatment Patients With Severe Community-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Lipoprotein-associated coagulation inhibitor</mesh_term>
	<criteria>Diagnosis communityacquired pneumonia support additional clinical , radiological , microbiological evidence Pneumonia sufficient severity require ICU admission management Pregnancy Weight 150 kg Patients increase risk bleeding Treatment drotrecogin alfa anticipate need drotrecogin alfa Treatment heparin anticipate need heparin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>